The Scientist Behind Some of the World ’s Best Coronavirus Images
From her laboratory in the far western reaches of Montana, Elizabeth Fischer is trying to help people see what they’re up against in COVID-19.
Over the past three decades, Fischer, 58, and her team at the Rocky Mountain Laboratories, part of the National Institutes of Health’s (NIH) National Institute of Allergy and Infectious Diseases, have captured and created some of the more dramatic images of the world’s most dangerous pathogens.
“I like to get images out there to try to convey that this is an entity, to try to demystify it, so this is something more tangible for people,” says Fischer, on...
Source: TIME: Science - May 20, 2020 Category: Science Authors: Markian Hawryluk / Kaiser Health News Tags: Uncategorized COVID-19 Source Type: news
US inroads to better Ebola vaccine
(Flinders University) As the world focuses on finding a COVID-19 vaccine, research continues on other potentially catastrophic pandemic diseases, including Ebola and Marburg viruses. In the latest collaboration with US partners, a vaccine turbocharger called Advax adjuvant, was combined with a synthetic protein against Ebola developed by the United States Army Medical Research Institute of Infectious Disease (USAMRIID). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 18, 2020 Category: International Medicine & Public Health Source Type: news
Ebola virus disease – Democratic Republic of the Congo
From 6 to 12 May 2020, no new cases of Ebola virus disease (EVD) have been reported from North Kivu Province, Democratic Republic of the Congo (Figure 1). Since the resurgence of the outbreak on 10 April 2020, seven confirmed cases have been reported from Kasanga, Malepe and Kanzulinzuli Health Areas in Beni Health Zone. Of these, one is receiving care at the Beni Ebola treatment centre (ETC), one who was receiving care at the ETC recovered and was discharged, and one remains in the community, 35 days after symptom onset. Efforts to locate this individual are being undertaken to test and provide care for this person. Four ...
Source: WHO Disease Outbreaks - May 14, 2020 Category: Infectious Diseases Tags: news Source Type: news
How Pandemics End
An infectious outbreak can conclude in more ways than one, historians say. But for whom does it end, and who gets to decide? (Source: NYT Health)
Source: NYT Health - May 10, 2020 Category: Consumer Health News Authors: Gina Kolata Tags: Epidemics Coronavirus (2019-nCoV) Plague Smallpox Ebola Virus Influenza Epidemic (1918-19) Rats Antibiotics Bubonic Plague Fleas Microbiology Deaths (Fatalities) Vaccination and Immunization your-feed-science your-feed-health Source Type: news
Why Infectious Diseases Like COVID-19 Make Science Move So Fast
This article is part of #TIME100Talks: Finding Hope, a special series featuring leaders across different fields sharing their ideas for navigating the pandemic. Want more? Sign up for access to more virtual events, including live conversations with influential newsmakers. (Source: TIME: Health)
Source: TIME: Health - May 8, 2020 Category: Consumer Health News Authors: Mandy Oaklander Tags: Uncategorized COVID-19 TIME 100 TIME100 Talks video Source Type: news
The Baltimore Bioterrorism Expert Who Inspired South Korea ’s COVID-19 Response
On Oct. 2, 2001, a 62-year-old photojournalist named Bob Stevens became the first victim of a coordinated series of anthrax attacks to be admitted to hospital. Stevens inhaled the deadly pathogen after opening one of several letters laced with anthrax spores which were mailed to the offices of prominent senators and media outlets across the U.S. Over the next seven weeks, he and four others would die as a result of their exposure.
For a shell-shocked nation still reeling from the single deadliest terrorist attack in human history on September 11, it was a disturbing realization that there was a new wave of challenges to Am...
Source: TIME: Health - May 6, 2020 Category: Consumer Health News Authors: David Cox Tags: Uncategorized COVID-19 Source Type: news
Polio, Measles Outbreaks ‘Inevitable’, Say Vaccine Experts
A young boy in Pakistan receives an oral polio vaccine (OPV). Credit: Ashfaq Yusufzai/IPSBy Laura MackenzieMay 6 2020 (IPS) Interruptions to vaccination programmes caused by the COVID-19 pandemic could result in new waves of measles or polio outbreaks, health experts warn.
A growing number of one-off immunisation campaigns and national routine vaccine introductions are being delayed amid social distancing and other measures to curb the spread of SARS-CoV-2, leaving millions unprotected.
With both preventive campaigns and routine immunisations impacted, “we’ll have an increasing number of children who will become suscep...
Source: IPS Inter Press Service - Health - May 6, 2020 Category: International Medicine & Public Health Authors: Laura Mackenzie Tags: Global Headlines Health TerraViva United Nations Source Type: news
Global Impact of New Corona Virus and Population Issues
By Osamu KusumotoTOKYO, May 5 2020 (IPS) The new coronavirus (COVID-19) continues to wreak havoc across the world, as the number of infections and deaths rapidly rise. It has the potential to infect anybody regardless of age or gender. There are grave concerns that the economic fallout from COVID-19 may be comparable to that of the Great Depression. According to Johns Hopkins Coronavirus Resource Center, there are 2,064,668 confirmed cases of COVID-19 and 137,124 deaths due to SARS-CoV-2 (the virus causing COVID-19). In Japan as of noon April 15, there were 8,100 cases of COVID-19 , 119 deaths, and 901 patients discharged ...
Source: IPS Inter Press Service - Health - May 5, 2020 Category: International Medicine & Public Health Authors: Osamu Kusumoto Tags: Asia-Pacific Economy & Trade Global Headlines Health Humanitarian Emergencies Poverty & SDGs Source Type: news
Coronavirus: With pressure growing, global race for a vaccine intensifies
Some experts say the more immediately promising field might be the development of treatments to speed recovery from Covid-19, an approach that has generated some optimism in the last week through initially encouraging research results on remdesivir, an antiviral drug previously tried in fighting Ebola. (Source: The Economic Times)
Source: The Economic Times - May 2, 2020 Category: Consumer Health News Source Type: news
Ebola virus disease – Democratic Republic of the Congo
From 22 to 28 April 2020, one new confirmed case of Ebola virus disease (EVD) was reported from Beni Health Zone in North Kivu Province, Democratic Republic of the Congo (Figure 1). This person was listed as a contact of a confirmed case, a family member who was reported on 17 April. The person was vaccinated on 20 April and was followed by the contact tracing team, though not on a regular basis due to insecurity. Since the resurgence of the outbreak on 10 April 2020, seven confirmed cases have been reported, all from Beni Health Zone. Of these, one is receiving care at the Beni Ebola treatment centre (ETC), one who was r...
Source: WHO Disease Outbreaks - April 30, 2020 Category: Infectious Diseases Tags: news Source Type: news
Statement of Support on Access to New COVID-19 Tools
Johnson & Johnson fully endorses the goals of the Global Collaboration to Accelerate Development, Production and Equitable Access to New COVID-19 Tools. As the largest and most comprehensive healthcare company in the world, Johnson & Johnson has been at the forefront of public health challenges, from antibiotics for TB to treatments for HIV and other infectious diseases and developing vaccines for HIV, Ebola, Zika, and much more. We began working on a vaccine for COVID-19 the moment the sequence was announced and recently announced the selection of a lead COVID-19 vaccine candidate. We are accelerating our research...
Source: Johnson and Johnson - April 24, 2020 Category: Pharmaceuticals Tags: Corporate Source Type: news
Meet Violet, the Robot That Can Kill the COVID-19 Virus
In just a few months, the COVID-19 pandemic has crossed borders and oceans, killing thousands, sickening millions, and forcing millions more to reckon with the economic and personal chaos of closures and lockdowns.
Yet as the global infection count rises, the crisis has also given rise to acts of ingenuity. The pandemic has set off a global race for both an effective vaccine and for the accurate, rapid-response tests that will be necessary before workplaces can safely reopen. Vaccines and tests are essential, but they’re not the only front on which to combat the virus.
In the face of an urgent threat, scientists have...
Source: TIME: Health - April 24, 2020 Category: Consumer Health News Authors: Corinne Purtill Tags: Uncategorized COVID-19 Source Type: news
Meet Violet, the Robot That Can Kill the COVID-19 Virus
In just a few months, the COVID-19 pandemic has crossed borders and oceans, killing thousands, sickening millions, and forcing millions more to reckon with the economic and personal chaos of closures and lockdowns.
Yet as the global infection count rises, the crisis has also given rise to acts of ingenuity. The pandemic has set off a global race for both an effective vaccine and for the accurate, rapid-response tests that will be necessary before workplaces can safely reopen. Vaccines and tests are essential, but they’re not the only front on which to combat the virus.
In the face of an urgent threat, scientists have...
Source: TIME: Science - April 24, 2020 Category: Science Authors: Corinne Purtill Tags: Uncategorized COVID-19 Source Type: news
Johnson & Johnson Announces Collaboration to Expand Manufacturing Capabilities For its COVID-19 Vaccine Candidate in Support of the Company ’s Goal to Supply More Than One Billion Vaccine Doses Globally
NEW BRUNSWICK, N.J., April 23, 2020 - Johnson & Johnson (the Company) (NYSE: JNJ) today announced a collaboration between the Janssen Pharmaceutical Companies of Johnson & Johnson and Emergent BioSolutions, Inc. to support the manufacturing of its lead investigational COVID-19 vaccine candidate. This is the first in a series of prospective global collaboration agreements designed to accelerate manufacturing of Johnson & Johnson’s COVID-19 vaccine candidate, and further the Company’s goal to supply more than one billion doses of the vaccine globally. Paul Stoffels, M.D., Vice Chairman of the Executive Commit...
Source: Johnson and Johnson - April 23, 2020 Category: Pharmaceuticals Tags: Our Company Source Type: news
What is the Ebola Virus?
Source: Council on Foreign Relations. Published: 4/20/2020.
This resource, updated on April 20, 2020, provides background information about the Ebola virus, where it has occurred, and how it is contained. It discusses how response partners have continued to struggle to control the disease, despite the use of an experimental vaccine, as a new outbreak in the Democratic Republic of the Congo in 2018 grew to become the second largest ever.
(Text) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 20, 2020 Category: International Medicine & Public Health Source Type: news
